Gigantism in mice lacking suppressor of cytokine signalling-2

Nature

Volumn 405, Issue 6790, 2000, Pages 1069-1073

  Metcalf, Donald ^a   Greenhalgh, Christopher J ^a   Viney, Elizabeth ^a   Wilison, Tracy A ^a   Starr, Robyn ^a   Nicola, Nicos A ^a   Hilton, Douglas J ^a   Alexander, Warren S ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PROTEIN; SOMATOMEDIN C; SUPPRESSOR OF CYTOKINE SIGNALLING 2; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; GIGANTISM; LEG LENGTH; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; BODY WEIGHT; CYTOKINES; DNA-BINDING PROTEINS; FEMALE; GIGANTISM; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED C57BL; MUTAGENESIS; PROTEINS; RECOMBINATION, GENETIC; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; STEM CELLS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATORS;

ANIMALIA; JANUS;

EID: 0034729710     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35016611     Document Type: Article

References (25)

1. Starr, R. et al. A family of cytokine-inducible inhibitors of signalling. Nature 387, 917-921 (1997).
2. Hilton, D. J. Negative regulators of cytokine signal transduction. Cell Mol. Life Sci. 55, 1568-1577 (1999)
3. Schoenle, E., Zapf, J., Humbel, R. E. & Froesch, E. R. Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 296, 252-253 (1982).
4. Jones, J. I. & Clemmens, D. R. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev. 16, 3-34 (1995).
5. Shobe, L., An, M. R., Frank, S. J. & Lowe, W. L. Developmental regulation of insulin-like growth factor-I and growth hormone receptor gene expression. Mol. Cell. Endocrinol. 152, 125-136 (1999).
6. Mathews, L. S., Enberg, B. & Norsledt, G. Regulation of rat growth hormone receptor gene expression. J. Biol. Chem. 264, 9905-9910 (1989).
7. Kopchick, J. J., Bellush, L. L. & Coschigano, K. T. Transgenic models of growth hormone action. Annu. Rev. Nutrition 19, 437-461 (1999).
8. Daughaday, W. H. in Endocrinology (ed. DeGroot, L. J.) 303-329 (W. B. Saunders Company, Philidelphia, 1995).
9. Quaife, C. J. et al. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 124, 40-48 (1989).
10. Wanke, R. et al. Overgrowth of skin in growth hormone transgenic mice depends on the presence of male gonads. J. Invest. Dermatol. 113, 967-971 (1999).
11. Norstedt, G. & Palmiter, R. Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver. Cell 36, 805-812 (1984).
12. Yakar, S. et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl Acad. Sci. USA 96, 7324-7329 (1999).
13. Sjogren, K. et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-1 in blood but is not required for postnatal body growth in mice, Proc. Natl Acad. Sci. USA 96, 7088-7092 (1999).
14. Adams. T. E. et al. Growth hormone proferentially induces the rapid, transient expression of SOCS 3, a novel inhibitor of cytokine receptor signaling. J. Biol. Chem. 273, 1285-1287 (1998).
15. Favre, H., Benhamou, A., Finidori, J., Kelly, P. A. & Edery, M. Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction. FEBS Lett. 453, 63-66 (1999).
16. Tollet-Egnell, P., Flores-Morales, A., Stavreus-Evers, A., Sahlin, L. & Norstedt, G. Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat. Endocrinology 140, 3693-3704 (1999).
17. Davey, H. W., McLachlan, M. J., Wilkins, R. J., Hilton, D. J. & Adams, T. E. STAT5h mediates the growth hormone-induced expression of SOCS-2 and SOCS-3 mRNA in the liver. Mol. Cell. Endocrinol 158, 111-116 (1999).
18. Ram, P. A. & Waxman, D. J. SOCS/CIS protein inhibition of growth hormone stimulation STAT5 signaling by multiple mechanisms. J. Biol. Chem. 274, 35553-35561 (1999).
19. Hansen, J. A., Lindberg, K., Hilton, D. J., Nielsen, J. H. & Billestrup, N. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins. Mol. Endocrinol. 13, 1832-1843 (1999).
20. Matsumoto, A. et al. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-indudble SH2 containing protein 1 transgenic mice. Mol. Cell. Biol. 19, 6396-6407 (1999).
21. Dey, B. R., Spence, S. L. Nissley, P. & Furlanetto, R. W. Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor. J. Biol. Chem. 273, 24095-24101 (1998).
22. Lopaczynski, W. Differential regulation of signaling pathways for insulin and insulin-like growth factor I. Acta Biochim. Pol. 46, 51-60 (1999).
23. Starr, R. et al. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signalling-1. Proc. Natl Acad. Sci. USA 95, 14395-14399 (1998).
24. Alexander, W. S., Metcalf, D. & Dunn, A. R. Point mutations within a dimer interface homolgy domain of c-mpl induce constitutive receptor activity and tumorigenesis. EMBO J. 14, 5569-5578 (1995).
25. Alexander, W. S., Roberts, A. W. Nicola, N. A., Li, R. & Metcalf, D. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood 87, 2162-2170 (1996).